Premium
Ketoconazole does not effect the systemic conversion of losartan to E‐3174
Author(s) -
McCrea J. B.,
Lo M.W.,
Furtek C.I.,
Ritter M.A.,
Alexandra Carides B.A.,
Waldman S.A.,
Bjornsson T. D.,
Goldberg M. R.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.177
Subject(s) - clinical pharmacology , ketoconazole , losartan , pharmacology , medicine , losartan potassium , angiotensin ii , receptor , dermatology , antifungal
Clinical Pharmacology & Therapeutics (1996) 59 , 169–169; doi: 10.1038/sj.clpt.1996.177
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom